These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3082393)

  • 1. The eosinophilic granulocyte an active participant in the late phase asthmatic reaction?
    Bruijnzeel PL; de Monchy JG; Verhagen J; Kauffman HF
    Bull Eur Physiopathol Respir; 1986; 22 Suppl 7():54-61. PubMed ID: 3082393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possible role of particular leukotrienes in the allergen-induced late-phase asthmatic reaction.
    Bruynzeel PL; Verhagen J
    Clin Exp Allergy; 1989 Jan; 19 Suppl 1():25-32. PubMed ID: 2653576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophils in bronchial asthma.
    Górski P; Palczyński C
    Allergol Immunopathol (Madr); 1989; 17(2):113-6. PubMed ID: 2528270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an eosinophil chemotaxis inhibitor, TAK-661, on antigen-induced asthmatic responses in allergic sheep.
    Fujimoto K; Tsunoda T; Koizumi T; Kubo K
    Lung; 2002; 180(3):161-72. PubMed ID: 12177730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The eosinophil and bronchial asthma].
    Fukuda T
    Nihon Rinsho; 1993 Mar; 51(3):752-8. PubMed ID: 8492453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced leukotriene C4 production by peripheral eosinophilic granulocytes from children with asthma.
    Schauer U; Eckhart A; Müller R; Gemsa D; Rieger CH
    Int Arch Allergy Appl Immunol; 1989; 90(3):201-6. PubMed ID: 2512259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB
    Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence of the harmful effects of eosinophils in bronchial asthma].
    Mehić B; Konjicija A; Zutić H; Lukić Z
    Plucne Bolesti; 1990; 42(1-2):104-6. PubMed ID: 2217619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils in asthma.
    Busse WW; Sedgwick JB
    Ann Allergy; 1992 Mar; 68(3):286-90. PubMed ID: 1546825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential generation of leukotriene C4 by human eosinophils.
    Shaw RJ; Cromwell O; Kay AB
    Clin Exp Immunol; 1984 Jun; 56(3):716-22. PubMed ID: 6086189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of TMK688, a novel anti-allergic drug having both 5-lipoxygenase inhibitory activity and anti-histamine activity, against bronchoconstriction, leukotriene production and inflammatory cell infiltration in sensitized guinea pigs.
    Tohda Y; Nakajima S; Shizawa T; Maeda K; Ohmori S; Satoh H; Ishii T; Kamitani T
    Clin Exp Allergy; 1997 Jan; 27(1):110-8. PubMed ID: 9117875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of mast cells to the late-phase of allergic asthma in rats.
    Liu S; Chihara K; Maeyama K
    Inflamm Res; 2005 May; 54(5):221-8. PubMed ID: 15953994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eosinophil cationic protein as a marker of eosinophil activity].
    Czerwionka-Szaflarska M; Gasiorowska J
    Przegl Lek; 2006; 63(7):579-82. PubMed ID: 17203813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan.
    Bruynzeel PL; Kok PT; Hamelink ML; Kijne AM; Verhagen J
    FEBS Lett; 1985 Sep; 189(2):350-4. PubMed ID: 2995125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.
    Fornhem C; Peterson CG; Dahlbäck M; Scheynius A; Alving K
    Clin Exp Allergy; 1996 Dec; 26(12):1436-48. PubMed ID: 9027445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of leukotriene C4 production by eosinophils from asthmatic and from normal subjects.
    Hodges MK; Weller PF; Gerard NP; Ackerman SJ; Drazen JM
    Am Rev Respir Dis; 1988 Oct; 138(4):799-804. PubMed ID: 3144208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of blood eosinophilia and the eosinophil cationic protein (ECP) in the serum of asthmatic children with varying degree of severity.
    Vilá-Indurain B; Muñoz-López F; Martín-Mateos M
    Allergol Immunopathol (Madr); 1999; 27(6):304-8. PubMed ID: 10611555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions.
    Piliponsky AM; Pickholtz D; Gleich GJ; Levi-Schaffer F
    J Allergy Clin Immunol; 2001 Jun; 107(6):993-1000. PubMed ID: 11398076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride.
    Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S
    Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.